01815nam a2200337 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020002600112020002500138020002600163020002700189040002100216035002100237050002500258082001800283245012700301260003600428300003700464504005100501505053300552533015201085650002201237655002901259700002701288710001701315856012601332999001901458ebr10490613CaPaEBRm        u        cr cn|||||||||100616s2011    njua    sb    001 0 eng d  z  2010025372  z9780470455630 (cloth)  z9780470934685 (ePub)  z9780470929353 (oBook)  z9780470929346 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)74659844514aRM411b.A5753 2011eb04a615/.792422200aAntiviral drugsh[electronic resource] :bfrom basic discovery through clinical trials /cedited by Wieslaw M. Kazmierski.  aHoboken, N.J. :bWiley,cc2011.  axiii, 438 p. :bill. (some col.)  aIncludes bibliographical references and index.0 apt. 1. Human immunodeficiency virus. section 1. HIV protease inhibitors ; section 2. HIV non-nucleoside reverse transcriptase inhibitors ; section 3. HIV nucleoside reverse transcriptase inhibitors ; section 4. HIV entry inhibitors ; section 5. HIV integrase inhibitors -- pt. 2. Hepatitis C virus. section 6. Protease inhibitors ; section 7. HCV polymerase nucleoside inhibitors ; section 8. Other HCV inhibitors -- pt. 3. Respiratory syncytial virus inhibitors -- pt. 4. Influenza, Hepatitis B, and Cytomegalovirus inhibitors.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aAntiviral agents. 7aElectronic books.2local1 aKazmierski, Wieslaw M.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10490613zAn electronic book accessible through the World Wide Web; click to view  c229848d229848